Immuno-Oncology 360° Speakers
Ian McCaffery, PhD
Head, Companion Diagnostics, Oncology Biomarker Development
Ian McCaffery, PhD, leads the Companion Diagnostic Development group at Genentech, developing and clinically validating predictive and prognostic diagnostic markers and associated technology platforms across the Genentech Research and Early Development and Roche Product Development portfolio.
Dr McCaffery has over 15 years experience in the Biotechnology industry, leading target, biomarker and companion diagnostic discovery and development programs in Research and Early/Late Stage Clinical Development. Previously, Dr McCaffery spent eight years in the Medical Sciences Department at Amgen leading the Oncology Therapeutic Area Biomarker Group, with accountability for all early and late stage biomarker development.
Dr McCaffery received his PhD from the University of Leeds, UK and gained postdoctoral experience at the University of Virginia investigating mechanisms of gene regulation.